NM_003242.6:c.1524+1279T>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003242.6(TGFBR2):c.1524+1279T>A variant causes a intron change. The variant allele was found at a frequency of 0.86 in 152,304 control chromosomes in the GnomAD database, including 56,744 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.86 ( 56744 hom., cov: 33)
Consequence
TGFBR2
NM_003242.6 intron
NM_003242.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 4.17
Publications
10 publications found
Genes affected
TGFBR2 (HGNC:11773): (transforming growth factor beta receptor 2) The protein encoded by this gene is a transmembrane protein that has a protein kinase domain, forms a heterodimeric complex with TGF-beta receptor type-1, and binds TGF-beta. This receptor/ligand complex phosphorylates proteins, which then enter the nucleus and regulate the transcription of genes related to cell proliferation, cell cycle arrest, wound healing, immunosuppression, and tumorigenesis. Mutations in this gene have been associated with Marfan Syndrome, Loeys-Deitz Aortic Aneurysm Syndrome, and the development of various types of tumors. Alternatively spliced transcript variants encoding different isoforms have been characterized. [provided by RefSeq, Aug 2017]
TGFBR2 Gene-Disease associations (from GenCC):
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Loeys-Dietz syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, G2P
- Loeys-Dietz syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.958 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.860 AC: 130922AN: 152186Hom.: 56682 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
130922
AN:
152186
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.860 AC: 131045AN: 152304Hom.: 56744 Cov.: 33 AF XY: 0.862 AC XY: 64202AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
131045
AN:
152304
Hom.:
Cov.:
33
AF XY:
AC XY:
64202
AN XY:
74454
show subpopulations
African (AFR)
AF:
AC:
40159
AN:
41586
American (AMR)
AF:
AC:
13243
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
2608
AN:
3468
East Asian (EAS)
AF:
AC:
4535
AN:
5188
South Asian (SAS)
AF:
AC:
4020
AN:
4828
European-Finnish (FIN)
AF:
AC:
9213
AN:
10596
Middle Eastern (MID)
AF:
AC:
224
AN:
294
European-Non Finnish (NFE)
AF:
AC:
54586
AN:
68014
Other (OTH)
AF:
AC:
1757
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
949
1898
2847
3796
4745
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
894
1788
2682
3576
4470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3060
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.